STOCK TITAN

Entera Bio Ltd. Ordinary Shares - ENTX STOCK NEWS

Welcome to our dedicated news page for Entera Bio Ltd. Ordinary Shares (Ticker: ENTX), a resource for investors and traders seeking the latest updates and insights on Entera Bio Ltd. Ordinary Shares.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Entera Bio Ltd. Ordinary Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Entera Bio Ltd. Ordinary Shares's position in the market.

Rhea-AI Summary
Entera Bio Ltd. (NASDAQ: ENTX) reports that the ASBMR has submitted a qualification plan to the FDA to use the treatment-related change in bone mineral density (BMD) as a surrogate endpoint for fractures in future trials of new anti-osteoporosis drugs. This is a critical step for osteoporosis drug innovation and could potentially impact the development of EB613, the first oral, osteoanabolic once-daily tablet treatment for osteoporosis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.66%
Tags
-
Rhea-AI Summary
Entera Bio and OPKO Biologics enter into a Research Collaboration Agreement for the development of oral tablet formulations using Entera's oral delivery technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
-
Rhea-AI Summary
Entera Bio Ltd. (NASDAQ: ENTX) to participate in investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.86%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.36%
Tags
none
Entera Bio Ltd. Ordinary Shares

Nasdaq:ENTX

ENTX Rankings

ENTX Stock Data

70.96M
24.89M
19.9%
10.47%
0.25%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
JERUSALEM

About ENTX

entera bio ltd. is a biotechnology company located in israel.